Matrivax Research & Development Corporation is a Boston-based company that is dedicated to developing life-saving vaccines to combat pneumococcal disease and Clostridiodes difficile infections. With a focus on breakthrough science, they are working on a next-generation pneumococcal vaccine to significantly reduce the global impact of this disease, which still causes over 1,000,000 deaths annually worldwide. Additionally, they are developing a novel C. difficile vaccine that targets both the bacteria and toxins, aiming to prevent bacterial colonization and toxicity, addressing the urgent public health threat posed by this infection that causes an estimated half a million infections in the US alone.
Generated from the website